Apogee Therapeutics Inc (APGE) PT Raised to $97 at RBC Capital

June 8, 2026 5:19 AM

RBC Capital analyst Brian Abrahams raised the price target on Apogee Therapeutics Inc (NASDAQ: APGE) to $97.00 (from $82.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found